Two Patients, Two Very Different Stories

"I crashed my car again," a college freshman, whom I'll call John, confessed to me during a session. At 19, John had been struggling with untreated attention-deficit/hyperactivity disorder (ADHD) for years. His impulsivity and distractibility didn't just cost him grades or lost keys – they nearly cost him his life.

One night, texting at a red light, he sped off without looking and plowed into another car. Thankfully no one was seriously hurt, but it was a wake-up call. When John finally received treatment for ADHD, including a stimulant medication, the effect was dramatic. His driving improved and the near-misses stopped. He could focus longer at work and defuse his temper before it got him into trouble. In short, medication helped John feel better and live safer, steering him away from the kinds of disasters that once felt almost inevitable.

Not all of my patients have such harrowing backstories. Take another patient, "Jane," a 28-year-old graphic designer who was never a daredevil and never in legal trouble. In school she was the quiet daydreamer who just got by. Only after college did she seek help for difficulties in concentration and forgetfulness that hindered her job performance.

When I diagnosed her with ADHD, she was relieved – it felt like finally "connecting the dots" on years of struggle. Starting medication was life-changing in subtle but meaningful ways: She could finish tasks on time and found her mind less cluttered. But Jane's story lacks the dramatic cliffhangers of John's – she wasn't on a path to car crashes or arrest even before treatment. Her biggest "real-world harm" was the risk of getting fired or feeling like a failure, not winding up in the ER.

And this difference between John and Jane turns out to be key to understanding a new paradox in ADHD treatment.

The Proven Benefits of ADHD Medication

For decades, doctors have known that ADHD medications don't just ease distraction in the classroom – they can also prevent some truly dire outcomes. Research from Sweden and the United States has shown that being on ADHD medication is associated with lower rates of self-harm, traffic accidents, and even criminal arrests.

In one landmark Swedish study, for example, medication use was linked to roughly a 30-40% reduction in criminal convictions. Another study found about a 40% drop in car crashes during medicated periods. In plain terms, treating ADHD in high-risk individuals can be the difference between a productive life and a tragedy.

These findings have justifiably been cited as proof that treating ADHD isn't only about improving report cards – it's literally about saving lives and livelihoods.

The Paradox: Medications Work, But Benefits Are Shrinking

Yet recently, as ADHD has gone from a niche diagnosis to a household term, something curious has emerged: the medications still work, but their biggest benefits appear to be getting smaller.

A new nationwide study from Sweden, published in JAMA Psychiatry this year, examined nearly 247,000 people with ADHD from 2006 to 2020. The researchers, led by Dr. Lin Li, confirmed that when individuals were on ADHD medication, they consistently had lower rates of serious outcomes – including self-injury, accidents, and arrests – compared to when they were off medication.

However, the strength of those protective effects has weakened over time:

The medications hadn't stopped working – individuals still saw real improvements. But the dramatic, life-saving differences that characterized early ADHD treatment research were becoming less pronounced.

Why Is This Happening? The Expanding Diagnosis

To understand this trend, we need to look at who's being diagnosed with ADHD now versus 20 years ago.

Then: Severe Cases Like John

Historically, ADHD diagnosis was reserved for people with severe, obvious symptoms – the Johns of the world who were:

When you treat this population with medication, you see dramatic results: fewer accidents, fewer arrests, fewer ER visits. The intervention is preventing catastrophic outcomes.

Now: A Broader Spectrum Including Jane

Today, awareness of ADHD has expanded dramatically. We now recognize that ADHD exists on a spectrum and can present in subtle ways. This is largely positive – it means people like Jane, who might have struggled silently for years, can now get help.

But it also means the ADHD population now includes many people who were never at high risk for car crashes or criminal behavior in the first place. Their ADHD is real and treatment helps them – but the benefits are measured in:

These are meaningful improvements! But they don't show up as dramatically in statistics about hospitalizations or arrests.

The Statistical Reality: Dilution of Effect Size

Imagine studying the effectiveness of a life jacket by looking at two groups:

Group A: People who can't swim at all, thrown into deep water
Group B: Mix of non-swimmers, weak swimmers, and competent swimmers in varying water depths

In Group A, life jackets would show a dramatic effect on preventing drowning. In Group B, life jackets still help, but the effect size appears smaller because many people wouldn't have drowned anyway.

This is essentially what's happening with ADHD medication research:

The medication hasn't gotten weaker. The population receiving it has changed.

What This Means for Patients and Doctors

For Patients Like John: Treatment Is Still Critical

If you have severe ADHD with high-risk behaviors, medication can be life-saving. The research still strongly supports treatment:

Don't let anyone tell you medication doesn't work. For people like John, it absolutely does.

For Patients Like Jane: Treatment Still Valuable

If you have milder ADHD, you might not see dramatic "life-saving" effects, but treatment still offers substantial benefits:

These improvements may not prevent car crashes (because you weren't at high risk anyway), but they're still life-changing for quality of life.

For Doctors: Individualized Treatment Decisions

This research underscores the importance of individualized treatment decisions. Not everyone with ADHD needs medication, and not everyone will benefit equally.

Questions to consider:

For severe ADHD with safety concerns (like John), medication should be strongly recommended. For milder cases (like Jane), a more nuanced discussion about risks, benefits, and alternatives is appropriate.

The Bigger Picture: Destigmatization vs. Overdiagnosis

This research touches on a broader debate in psychiatry: How do we balance destigmatizing mental health conditions with avoiding overdiagnosis?

The Positive Side of Expanded Diagnosis

There are real benefits to recognizing ADHD more broadly:

The Concerns About Overdiagnosis

At the same time, there are legitimate concerns:

Finding the Right Balance

So how do we reconcile these competing concerns? Here's what the evidence suggests:

1. ADHD Is Real Across the Spectrum

Both severe and mild ADHD are legitimate neurodevelopmental conditions with biological basis. We shouldn't dismiss milder presentations as "not real ADHD."

2. Treatment Should Match Severity

Severe ADHD (like John):

Moderate ADHD:

Mild ADHD (like Jane):

3. Comprehensive Treatment Is More Than Pills

Regardless of severity, medication alone is rarely optimal. Effective ADHD treatment includes:

For more on comprehensive treatment, see the ADHD Treatment Guide.

What Does This Mean for the Future?

As ADHD diagnosis continues to expand, we can expect:

Research Challenges

Clinical Practice Evolution

Public Health Implications

Conclusion: Medications Work, Context Matters

The Swedish study delivers a nuanced message that resists simple headlines: ADHD medications are still effective, but their impact depends on who's taking them and what outcomes we measure.

For people with severe ADHD and high-risk behaviors, medication can be life-saving – preventing accidents, arrests, and self-harm. For people with milder symptoms, medication still helps, but the benefits are more about improved daily functioning and quality of life than preventing catastrophes.

Both types of benefit are real. Both matter.

The key is matching treatment intensity to symptom severity, considering individual circumstances, and not losing sight of comprehensive care that goes beyond just prescribing pills.

As we continue to expand awareness and diagnosis of ADHD, we must preserve the nuance: recognize the full spectrum of the condition while ensuring that those with the most severe needs still get the intensive support that can truly save their lives.

References

Li L, et al. Association of ADHD Medications With Serious Adverse Outcomes: A Self-controlled Case Series Analysis From Sweden. JAMA Psychiatry. 2026.

Chang Z, et al. Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry. 2014.

Dalsgaard S, et al. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood. Addiction. 2014.

Seeking ADHD Treatment in NYC?

Dr. Ryan Sultan is a board-certified psychiatrist specializing in adult ADHD at Columbia University. He provides comprehensive, evidence-based treatment including medication management, therapy, and coaching.

Schedule Your ADHD Evaluation →

Further Reading